A carregar...

Tumor suppressor ING4 inhibits estrogen receptor activity in breast cancer cells

Resistance to antiestrogen therapy remains a significant problem in breast cancer. Low expression of inhibitor of growth 4 (ING4) in primary tumors has been correlated with increased rates of recurrence in estrogen receptor-positive (ER+) breast cancer patients, suggesting a role for ING4 in ER sign...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast Cancer (Dove Med Press)
Main Authors: Keenen, Madeline M, Kim, Suwon
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5117803/
https://ncbi.nlm.nih.gov/pubmed/27895513
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BCTT.S119691
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!